Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Cyclophosphamide for Systemic Sclerosis
NCT00501995Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2001
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cyclophosphamide in systemic sclerosis (SSc), localized scleroderma, sponsored by Johns Hopkins University. Started Feb 2001; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
systemic sclerosis (SSc)localized scleroderma
Beyond the preview
Go deeper on NCT00501995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501995.